Airfinity hosting industry leader roundtable on the future of the RSV market
Posted on Jan 3, 2023
Airfinity is bringing together leading experts to discuss one of the biggest emerging markets in the pharma industry for a live, virtual roundtable.
Hosted by Analytics Director Dr Matt Linley, get an exclusive look at Airfinity's independent forecasts on RSV, which our panel of guest speakers will then explore and discuss key market drivers.
When: Tuesday 31 January, 8am PT / 11am ET / 4pm GMT
More Insights From Airfinity
Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases
Oct 10, 2022
18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers
Aug 25, 2022
Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir
Jul 25, 2022
COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market
Jul 15, 2022
AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination
Jul 13, 2022
Global wastage of COVID-19 vaccines could be 1.1 billion doses
Jul 11, 2022